ARTICLE | Company News
Compugen, Bayer deal
August 12, 2013 7:00 AM UTC
The companies partnered to research and develop antibody-based cancer immunotherapies against two undisclosed immune checkpoint regulators discovered by Compugen. Compugen will be responsible for anti...